Pull to refresh
Logo
Daily Brief
Following Why Ranks Sign Up
Robert A. Bradway

Robert A. Bradway

Chairman and Chief Executive Officer, Amgen

Appears in 1 story

Notable Quotes

"Imdelltra has rapidly become the standard of care for patients with relapsed extensive-stage small cell lung cancer." — 2025 Letter to Shareholders

Stories

Tarlatamab rewrites treatment for small-cell lung cancer as approvals spread worldwide

New Capabilities

Leading Amgen's oncology expansion strategy

For decades, patients with extensive-stage small-cell lung cancer who relapsed after chemotherapy had almost nowhere to turn — five-year survival rates sat around 3%. Now a drug that bridges the patient's immune cells to their tumor has won approval in both the United States and China.

Updated May 31